Vés al contingut

Joan Guinovart awarded the prestigious <i>Creu de Sant Jordi</i>

Images

Contact

Imatge
Press & Communications Section Head
Tel.+34 93 40 37255

The prize is one of the highest recognitions in Catalonia.

The IRB director is one of 27 individuals and 15 organizations honoured this year.

Joan J. Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona) has been awarded the prestigious "Creu de Sant Jordi" 2014 (St. Jordi's Cross), as announced by the Government of Catalonia today.

Guinovart, founder and director of the IRB and Professor of the University of Barcelona, recieves the prize “for the international projection of his work on metabolic disorders  associated with neurodegenerative diseases. Director, since 2005, of the Institute for Research in Biomedicine, in Barcelona, he has made valuable contributions to the education and projection of  science in Catalonia”.

This year, the Government of Catalonia has awarded 27 individuals and 15 organizations the Creu de Sant Jordi. The prize - one of the highest recognitions in Catalonia - was established in 1981 to honour outstanding individuals and organizations engaged in civic, social, cultural, economic, and political activities.

Official Press Release (Catalan)

SHORT BIO

Joan J Guinovart (Tarragona, 1947) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona. He is senior professor of Biochemistry and Molecular Biology at the same university and founder and director of IRB Barcelona since October 2005. Since Sptember 2012, he has served as president-elect of the International Union of Biochemistry and Molecular Biology (IUBMB).

He is a full member of the Royal Spanish Academy, the Catalan Academy of Arts and Science (Institut d’Estudis Catalans (IEC) and the Academia Europaea. He has received the "Narcís Monturiol" Medal from the Generalitat de Catalunya (Government of Catalonia), the “Prat de la Riba" prize from the IEC and the FEBS Diplôme d’Honneur, among other recognitions.

Dr. Guinovart’s research activity focuses on glycogen metabolism, which is closely related to diabetes and neurodegenerative disorders, such as Lafora disease. Guinovart leads the "Metabolic engineering and diabetes therapy" group at IRB, within the Molecular Medicine programme.

IRB Barcelona

L’Institut de Recerca Biomèdica (IRB Barcelona) treballa per aconseguir una vida lliure de malalties. Desenvolupa una recerca multidisciplinària d’excel·lència per curar el càncer i altres malalties vinculades a l'envelliment. Treballa establint col·laboracions amb la indústria farmacèutica i els principals hospitals per fer arribar els resultats de la recerca a la societat a través de la transferència de tecnologia, i du a terme diferents iniciatives de divulgació científica per mantenir un diàleg obert amb la ciutadania. L’IRB Barcelona és un centre internacional que acull al voltant de 400 investigadors de més de 30 nacionalitats. Reconegut com a Centre d'Excel·lència Severo Ochoa des de 2011, és un centre CERCA i membre del Barcelona Institute of Science and Technology (BIST).